Evidence map›Paper›PMID 35911181›Full record

ArticlePulmonary circulation2022

Prediction of patient outcomes through social determinants of health: The Pulmonary Hypertension Association Registry (PHAR) evaluation.

Dan Grinnan, Le Kang, Christine DeWilde, David Badesch, Raymond Benza, Todd Bull, Murali Chakinala, Teresa DeMarco, Jeremy Feldman, Hubert J Ford and 7 more

Open access · goldAbstract read
In one paragraph

Article in Pulmonary circulation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Exploring the patient perspective in pulmonary hypertension.The European respiratory journal · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 12 institutions in 1 country.

Dan GrinnanDepartment of Medicine Virginia Commonwealth University Richmond Virginia USA.ORCID 0000-0002-7620-6166
Le KangDepartment of Medicine Virginia Commonwealth University Richmond Virginia USA.
Christine DeWildeVictoria Johnson Research Center Virginia Commonwealth University Richmond Virginia USA.
David BadeschDepartment of Medicine University of Colorado Boulder Colorado USA.
Raymond BenzaDepartment of Medicine The Ohio State University Columbus Ohio USA.
Todd BullDepartment of Medicine University of Colorado Boulder Colorado USA.
Murali ChakinalaDepartment of Medicine Washington University Seattle Washington USA.
Teresa DeMarcoDepartment of Medicine University of California San Francisco San Francisco California USA.
Jeremy FeldmanDepartment of Medicine Arizona Pulmonary Specialists Phoenix Arizona USA.
Hubert J FordDepartment of Medicine University of North Carolina Chapel Hill North Carolina USA.
James KlingerDepartment of Medicine Brown University Providence Rhode Island USA.
John McConnellKentuckiana Pulmonary Associates Louisville Kentucky USA.
Erika B RosenzweigDepartment of Medicine Columbia University New York New York USA.
Jeffrey SagerCottage Pulmonary Hypertension Center Santa Barbara California USA.
Oksana ShlobinDepartment of Medicine INOVA Falls Church Virginia USA.
Roham ZamanianDepartment of Medicine Stanford University Stanford California USA.
PHAR Investigators
Virginia Commonwealth University · USUniversity of Colorado Boulder · USArizona Pain Specialists · USBrown University · USColumbia University · USInova Health System · USKentuckiana Pulmonary Associates · USStanford University · USThe Ohio State University · USUniversity of California, San Francisco · USUniversity of North Carolina at Chapel Hill · USUniversity of Washington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Outcomes of patients with pulmonary arterial hypertension (PAH) may be associated with social determinants of health (SDOH) and other baseline patient characteristics. At present, there is no prognostic model to predict important patient outcomes in PAH based on SDOH. Utilizing information from the Pulmonary Hypertension Association Registry (PHAR), we derive a model (PHAR Evaluation or PHARE) to predict an important composite patient outcomes based on SDOH and other patient characteristics. Baseline data regarding SDOH from adult patients with PAH enrolled in the PHAR between 2015 and March 23, 2020, were included for analysis. We performed repeated measures logistic regression modeling with dichotomous outcome data (0 for no events, 1 for one or more events) to derive the PHARE. Here, 1275 consecutive adult patients enrolled in the PHAR from 47 participating centers were included. Variables included in our model are race, gender, ethnicity, household income, level of education, age, body mass index, drug use, alcohol use, marital status, and type of health insurance. Interaction effect between variables was analyzed and several interactions were also included in the PHARE. The PHARE shows a

Indexed as

clinical registrypulmonary arterial hypertensionsocial determinants of health

Identifiers

PMID35911181
PMCPMC9330350
OpenAlexW4286716972

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.